CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

Polygenic screening of embryos is here, but is it ethical?

By Philip Ball, The Guardian [cites CGS' Katie Hasson] | 10.17.2021

Aggregated News

The birth of the first IVF baby, Louise Brown, in 1978 provoked a media frenzy. In comparison, a little girl named Aurea born by IVF in May 2020 went almost unnoticed. Yet she represents a significant first in assisted reproduction...

Genomics

Updated Map of US Surrogacy Policies Highlights Patchwork of State Regulation

By Emily Galpern | 11.17.2021
Biopolitical Times
The United States does not regulate surrogacy at a federal level, leaving each state to determine its own policies. The situations range from states with no laws that address surrogacy to those that prohibit it completely: some states have detailed legislation that addresses numerous aspects of surrogacy contracts...
Policies

The Planning Committee for the Third Summit: Now Who Decides?

By Pete Shanks | 11.18.2021
Biopolitical Times

A few months ago, under the title “Heritable Human Genome Editing: Who Decides Who Decides?” we analyzed the...

Policies

Campus professor Osagie K. Obasogie elected as member to the National Academy of Medicine

By Lydia Sidhom, The Daily Californian [cites CGS' Marcy Darnovsky] | 10.20.2021

Aggregated News

UC Berkeley professor of law and bioethics Osagie K. Obasogie was elected for membership to the National Academy of Medicine...

Civil Society

Biopolitical Times

Facts Are Facts, Opinions Not So Much

By Pete Shanks | 12.02.2021

Beth Shapiro describes herself as an evolutionary (paleo)biologist, which informs the title and much of the first half of this...

Human Genetic Modification

A Note on the Upcoming Human Genome Editing Summit

By Marcy Darnovsky | 11.19.2021

The Third International Summit on Human Genome Editing will be held in London on March 7–9, 2022. The three-day conference...

Policies

The Planning Committee for the Third Summit: Now Who Decides?

By Pete Shanks | 11.18.2021

A few months ago, under the title “Heritable Human Genome Editing: Who Decides Who Decides?” we analyzed the...

Policies

News

Gene-edited livestock: robust rules needed before approval, say ethicists

By Ian Sample, The Guardian | 12.01.2021

Robust regulations must be put in place to protect the welfare of farmed animals before genome-editing procedures are approved for commercial livestock, ethicists have warned.

Powerful gene-editing techniques have the potential to improve modern farming by making animals resistant to...

Synthetic Biology

Biology is a spectrum: Life on Earth is complex and irreducible

By Dan Samorodnitsky, Massive Science | 11.30.2021

If I placed before you an atom with one proton and one electron, you would be forced to admit it was a hydrogen atom. One proton paired with one electron is hydrogen. It can’t be helium, or lithium, or anything...

Biopolitics

The Genetic Lottery is a bust for both genetics and policy

By Kevin Bird, Massive Science | 11.29.2021

The last decade has seen genetics and evolution grapple with its history; one composed of figures who laid the foundations of their field while also promoting vile racist, sexist, and eugenicist beliefs.

In her new book, The Genetic Lottery...

U.S. Federal

Clampdown on useless IVF extras

By Ben Spencer, The Times | 11.28.2021

IVF clinics selling ineffective “add-on” treatments face fines as part of the biggest shake-up of fertility laws in 30 years.

Julia Chain, the new chairwoman of the Human Fertilisation and Embryology Authority, is seeking fundamental changes to the 1990 laws...

Policies

Video
A Dangerous Idea: Eugenics in America
Use Gene Editing to Treat Patients, Not Design Babies
CRISPR: What is the future of gene editing? | Start Here